MODIFICATION TO LAPIDUS PLATE
K070241 · New Deal, S.A. · HRS · Feb 8, 2007 · Orthopedic
Device Facts
| Record ID | K070241 |
| Device Name | MODIFICATION TO LAPIDUS PLATE |
| Applicant | New Deal, S.A. |
| Product Code | HRS · Orthopedic |
| Decision Date | Feb 8, 2007 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 888.3030 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The NEWDEAL Lapidus Plates are intended to be used for bone fixation such as: - Arthrodesis of the 1st metatarsocuneiform joint to reposition and stabilize a metatarsus primus varus - Lisfranc arthrodesis - Mono or bi-cortical osteotomies or fractures near the 1st metatarsocuneiform joint.
Device Story
Osteosynthesis plate system designed for 1st tarsometatarsal joint stabilization; includes plates, fixation screws, and washers. Locking mechanism utilizes washers drilled into threaded lipped sockets on plate to block screw heads, creating single plate/screw unit. Used by orthopedic surgeons in clinical settings for bone fixation procedures. Benefits patient by providing rigid stabilization for arthrodesis or fracture management.
Clinical Evidence
Bench testing only. Mechanical tests demonstrated that the modified Lapidus Plates have mechanical properties similar to the predicate device (K060476).
Technological Characteristics
Metallic bone fixation plate system; stainless steel locking mechanism; includes plates, screws, and washers; locking principle via washers secured into threaded lipped sockets to block screw heads.
Indications for Use
Indicated for patients requiring bone fixation for arthrodesis of the 1st metatarsocuneiform joint (to stabilize metatarsus primus varus), Lisfranc arthrodesis, or mono/bi-cortical osteotomies or fractures near the 1st metatarsocuneiform joint.
Regulatory Classification
Identification
Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.
Predicate Devices
Related Devices
- K060474 — LISFRANC PLATE · New Deal, S.A. · Aug 3, 2006
- K060476 — LAPIDUS PLATE · New Deal, S.A. · May 17, 2006
- K060473 — TTC PLATE · New Deal, S.A. · May 17, 2006
- K162179 — osteo-WEDGE II ® Open Wedge Bone Locking Plate System · Graham Medical Technologies, LLC Dba Gramedica · Jan 10, 2017
- K070160 — MODIFICATION TO TTC PLATES · New Deal, S.A. · Feb 8, 2007
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for Newdeal, an Integra LifeSciences Company. The logo features the word "newdeal" in a bold, sans-serif font, with the "n" connected to a circular graphic made of a thin line and four solid black circles. Below the word "newdeal" is the text "An Integra LifeSciences Company" in a smaller, italicized font. The logo is simple and modern, with a focus on the company name.
## 510(K) SUMMARY
FEB 8 2007
#### Lapidus Plates
# Submitter's name and address
Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52
## Contact person and telephone number
Morgane Grenier Regulatory and Clinical Affairs Director Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52
#### Alternate Contacts
## Authorized Agent in the United States
Judith E. O'Grady, RN, MSN Sr. Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536, USA Tel: (609) 936-2311 Fax: (609) 275-9445 E-mail: jogrady@integra-ls.com
#### Date Summary was prepared
January 23, 2007.
#### Name of the device
| Proprietary Name: | Lapidus Plate |
|-----------------------|-------------------------------------------------------------------------------------------------|
| Common Name: | Plate, Fixation, Bone |
| Classification Name: | Single/multiple component metallic bone fixation appliances and<br>accessories (21CFR 888.3030) |
| Device Product Code: | HRS |
| Classification Panel: | Orthopedic |
#### Substantial Equivalence
The modified Lapidus Plates (with stainless steel locking system) are substantially equivalent to commercially marketed device, Lapidus Plates, K060476.
## Device Description
The NEWDEAL® Lapidus Plate consists of an osteosynthesis plate designed to bridge the 1* tarsometatarsal joint, available in different sizes, which will be fixed using NEWDEAL® (ocking system fixation screws and washers. The NEWDEAL® locking System includes as many fixation
{1}------------------------------------------------
screws as there are threaded lipped sockets on the plate and as many washers as implanted screws. The NEWDEAL® locking system creates a single plate/screw unit fixed into the bone. The ostedsynthesis screws must be driven into the bone through the holes in the mo one. The system is locked by means of washers drilled into the threaded lipped socket at the top of each hole, thus blocking each screw head.
#### Intended Use
The NEWDEAL Lapidus Plates are intended to be used for bone fixation such as:
- Arthrodesis of the 1st metatarsocuneiform joint to reposition and stabilize a metatarsus primus varus
- Lisfranc arthrodesis
- Mono or bi-cortical osteotomies or fractures near the 1st metatarsocuneiform joint.
## Testing and Test Results
Mechanical tests have been carried out. Results have shown that the mechanical properties of the modified LAPIDUS PLATES are thus similar to the properties of the unmodified devices, Lapidus Plates, K060476.
#### Conclusion
The modified Lapidus Plates (with stainless steel locking system) are substantially equivalent to commercially marketed device, Lapidus Plates, K060476.
The modifications do not change the intended use or fundamental scientific technology of the device and do not raise any new issues of safety or effectiveness.
{2}------------------------------------------------
#### DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a traditional symbol of medicine, with a staff and intertwined snakes.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Newdeal SAS % Judith O'Grady, R.N., M.S.N. Senior Vice President, Regulatory Affairs Integra Lifesciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536
8 2007
Re: K070241 Trade/Device Name: Lapidus Plates Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS Dated: January 23, 2007 Received: January 25, 2007
Dear Ms. O'Grady:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
#### Page 2 - Judith O'Grady, R.N., M.S.N.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
barbare Onchins
for
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) Number (if known): K070241
Device Name:
Lapidus Plates
## Indications For Use:
The NEWDEAL Lapidus Plates are intended to be used for bone fixation such as: - Arthrodesis of the 1st metatares and stable to bout inkation such as:
primus your primus varus
- Lisfranc arthrodesis
- Mono or bi-cortical osteotomies or fractures near the 1st metatarsocuneiform joint.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Jombare Bmeum
(Division Sign-Off Division of General, Rest rative, and Neurological Devices
**510(k) Number** Ko70241
Page 1 of 1